29th June 2020 Content supplied by: Guangdong Wesail Biotech Co., Ltd.
Free Samples! WESAIL 5 Min CE-Marked IgM/IgG Antibody COVID-19 Test Kit
A Point of Care Testing (POCT) - focused brand, WESAIL Biotech Co., Ltd., striving to bring in more convenient, rapid and accurate tests to patients, launches CE-Marked IgM/IgG Antibody Test Kit to assist in early screening, infection stage evaluation and epidemiologic study of COVID-19.
The performances of WESAIL IgM/IgG Antibody Test Kit are comparable to top international brands by featuring below clinical benefits, sign up via WESAIL IgM/IgG for free samples today!
- 99% specificity & ≥90% sensitivity
- Result in 5 min
- Rapid detection of IgM & IgG antibodies in one single test
- Indication of both recent and previous infections
- No equipment needed, visual interpretation of results
- Easy operation, compatible with whole blood/serum/plasma
- Complementary to nucleic acid test to improve COVID-19 diagnosis
Guangdong WESAIL Biotech Co., Ltd., with its strong business philosophy of “strive for excellence, truth and reality”, attaches great importance to technology innovation, product technological experiments, and the research of product advancement. The company is committed to supporting IVD diagnostic partners with excellent performance reagents and analyzers for colloid gold and immunofluorescence platforms.
Based on deep insights into the future industry development trends, WESAIL continuously launches reagents and analyzers meeting customer needs in various disease areas, including cardiovascular, metabolism, fertility, inflammation, diabetes, hormone, brain injury, renal injury, thyroid, tumor marker, etc. By bringing in more convenient, rapid and accurate tests to patients,
WESAIL fulfills the essence of POCT products to the world and continues to maintain a leading technology level among players in the global POCT industry.
Website: en.wesailbio.com Phone: +86-769-22890969 or use the Request Information button below.
Date Published: 29th June 2020
Source article link: View